Günter Carl Hober
Managing Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references Quickcontact
ConAlliance is characterised by first-class M&A consulting expertise in the field of invasive surgery, which is set to shape the future of healthcare. From advanced ablation procedures to minimally invasive techniques, innovative surgical technologies are transforming patient outcomes and surgical precision. The role of cutting-edge tools and technologies in enhancing surgical capabilities is increasingly vital. ConAlliance's deep expertise across various areas of invasive surgery means that we are more than just investment bankers - we are strategic partners who will guide you to successful outcomes in this dynamic and evolving field.
Invasive surgery refers to medical procedures where the body is opened through cuts or punctures to access internal organs, tissues, or structures. These procedures are often performed to diagnose conditions, treat diseases, or repair injuries. This type of surgery encompasses a variety of techniques, medical products, medical technology, and medical devices, including, for example, gastric tubes, medical drainage, PICC catheters, endovenous laser therapy, KTP lasers, laser coagulation, high-frequency surgery, debridement, NOTES (Natural Orifice Translumenal Endoscopic Surgery), and high-frequency ablation.
Medtronic acquired Covidien for approximately $49.9 billion. This merger significantly expanded Medtronic's portfolio in surgical technologies and medical devices, enhancing its capabilities in minimally invasive procedures.
Johnson & Johnson acquired Synthes, a leading manufacturer of orthopedic devices, for $19.7 billion. This acquisition strengthened J&J's position in the orthopedic and spinal surgery markets.
Stryker Corporation acquired MAKO Surgical Corp., a pioneer in robotic-arm assisted surgery, for approximately $1.65 billion. This acquisition enhanced Stryker's capabilities in orthopedic surgery, particularly in joint replacement procedures.
Zimmer Holdings acquired Biomet for $13.4 billion, forming Zimmer Biomet. This merger combined two major players in the musculoskeletal healthcare market, enhancing their product offerings in orthopedic and minimally invasive surgery.
Medtronic acquired Mazor Robotics, a leader in robotic-assisted spine surgery, for approximately $1.64 billion. This acquisition strengthened Medtronic's portfolio in minimally invasive spine surgery technologies.
Boston Scientific acquired Augmenix, a company specializing in absorbable hydrogels used in radiation therapy for prostate cancer, for $500 million. This acquisition expanded Boston Scientific's urology and pelvic health business.
Smith & Nephew acquired ArthroCare Corporation, which developed minimally invasive surgical products, for $1.7 billion. This acquisition strengthened Smith & Nephew's sports medicine and ENT businesses.
Teleflex acquired NeoTract, which developed minimally invasive devices for urology, for up to $1.1 billion. This acquisition bolstered Teleflex's urology and surgical portfolio.
Abbott Laboratories acquired St. Jude Medical for $25 billion. St. Jude Medical specialized in cardiovascular and neuromodulation products, including minimally invasive solutions. This deal significantly expanded Abbott's medical device capabilities.
Stryker Corporation acquired K2M Group Holdings, which specialized in complex spine and minimally invasive solutions, for approximately $1.4 billion. This deal enhanced Stryker's spine surgery offerings.
Ten notable mergers and acquisitions in the invasive surgery niche that have taken place since 2020
This compilation is as of (date) 01 July 2024 and has not been updated since.
Medtronic, which had previously acquired a majority stake in Mazor Robotics, a company specializing in robotic guidance systems for spine surgery, completed the acquisition of the remaining stake. This move fully integrated Mazor's technology into Medtronic's portfolio.
Stryker Corporation acquired Wright Medical Group, a global medical device company focused on extremities and biologics, for approximately $4.7 billion. This acquisition strengthened Stryker's position in the orthopedic and trauma surgery market.
Boston Scientific acquired the surgical business of Lumenis, a company known for its laser and energy-based medical solutions, for $1.07 billion. This acquisition expanded Boston Scientific's capabilities in urology and ear, nose, and throat (ENT) procedures.
Teleflex, a global provider of medical technologies, acquired Z-Medica, a company specializing in hemostatic products, for up to $500 million. This acquisition enhanced Teleflex's surgical portfolio, particularly in bleeding control.
Smith & Nephew acquired the extremity orthopedics business of Integra LifeSciences for $240 million. This acquisition bolstered Smith & Nephew's position in the shoulder replacement and foot and ankle surgery markets.
Johnson & Johnson, through its subsidiary Ethicon, acquired Verb Surgical, a joint venture between J&J and Verily (an Alphabet company), focused on developing advanced robotic surgery solutions. This acquisition aimed to enhance J&J's digital surgery capabilities.
NuVasive, a spine technology company, acquired Simplify Medical, known for its cervical artificial disc technology, for $150 million. This acquisition expanded NuVasive's portfolio in minimally invasive spinal surgery.
Zimmer Biomet acquired A&E Medical, a company that provides sternal closure devices and various products for cardiothoracic surgery, for $250 million. This acquisition enhanced Zimmer Biomet's thoracic surgery offerings.
Olympus Corporation acquired Veran Medical Technologies, a company specializing in advanced minimally invasive interventional pulmonology solutions, for $340 million. This acquisition expanded Olympus' respiratory solutions portfolio.
Hologic, a global medical technology company, acquired Bolder Surgical, which develops advanced energy vessel sealing surgical devices, for $160 million. This acquisition enhanced Hologic's surgical solutions, particularly in the areas of gynecology and general surgery.
ConAlliance is one of the world's leading M&A advisors in this niche of invasive surgery due to the large number of successfully realised M&A transactions.
Peritoneal lavage, infrared coagulation, cryoneurolysis, endovenous laser therapy, endovenous radiofrequency therapy, varicocele sclerotherapy, drainage (medicine), vascular prosthesis, high-frequency surgery, percutaneous transhepatic cholangiography, PICC catheter, catheter ablation, cerebral protection system, cryoablation, debridement, ventricular puncture, high-frequency spinal cord stimulation, balloon catheter (medical technology), dialysis, high-frequency ablation, vertebroplasty, KTP laser, thoracic drainage, heart-lung machine, cardiac catheterization, periradicular therapy, embolectomy, Redon drain, decortication, feeding tube, parenteral nutrition, neurolysis, rotablation, mucosectomy, NOTES (natural orifice transluminal endoscopic surgery), thermoablation, Sengstaken tube, balloon dilation of the eustachian tube, Robinson drainage, ThuLEP, urethrotomy, external ventricular drainage, cricothyrotomy, laser coagulation, necrectomy, venous access, angioplasty, percutaneous laser disc decompression, percutaneous endoscopic gastrostomy, dermabrasion, revascularization, stent angioplasty, central venous catheter, conchotomy, radiosynovectomy, percutaneous transhepatic drainage, selective internal radiotherapy, liposuction, injection lipolysis, abrasion (medicine), gastric tube.
ConAlliance delivers comprehensive M&A advisory services to medical product companies across all major regions, encompassing sectors such as medical supplies, capital equipment, implantable devices, and more. In developed markets, our extensive experience with leading payors, providers, and regulators enables us to offer unparalleled advice for buying or selling a medical device company.
ConAlliance offers strategic advice on a full spectrum of medical device transactions, including:
In the realm of invasive surgery, several leading companies dominate the global market with their innovative technologies and extensive portfolios. Johnson & Johnson, known for their Ottava surgical robotics system and Monarch platform, stands at the forefront, alongside Medtronic, which offers the Hugo robotic surgery system and Mazor robotics for spine surgery. GE Healthcare excels in medical imaging and healthcare technologies, while Stryker is recognized for their Mako surgical robots used in orthopedic procedures. Intuitive Surgical pioneered the da Vinci surgical system, widely adopted for minimally invasive surgeries. Zimmer Biomet focuses on musculoskeletal healthcare and joint replacement technologies, and Siemens Healthineers provides advanced imaging and diagnostic solutions. Philips Healthcare specializes in diagnostic imaging and patient monitoring systems, Boston Scientific develops a range of medical devices for various surgical applications, and Smith & Nephew is known for orthopedic reconstruction, advanced wound management, and sports medicine products. Other significant players include Becton, Dickinson & Co. (BD), B. Braun Melsungen, 3M Healthcare, Abbott Laboratories, Tandem Diabetes Care, Bio-Techne, Insulet Corporation, Globus Medical, AtriCure, and Zynex.
These companies are instrumental in advancing invasive surgical techniques and technologies, offering a broad array of medical devices, surgical robotics, and minimally invasive solutions.
In the realm of M&A, it is crucial to distinguish between categories such as medicinal products, medical products, medical devices, food products, and cosmetics. For manufacturers, understanding the difference between medicinal products and medical devices is particularly important, as medicinal products require a marketing authorization before they can be sold. In contrast, medical devices only need to undergo a conformity assessment procedure, which is faster and less costly than obtaining a marketing authorization for medicinal products.